What is STEGLATRO?
+

What is STEGLATRO?

+

STEGLATROTM (ertugliflozin) is a prescription pill that, along with diet and exercise, helps lower blood sugar levels in adults with type 2 diabetes. STEGLATRO is not for people with type 1 diabetes and/or diabetic ketoacidosis (increased ketones in your blood or urine).

STEGLATRO is for adults with type 2 diabetes, in addition to diet and exercise. Not for treating type 1 diabetes or diabetic ketoacidosis.

 

 
 

FAQs about STEGLATRO

For answers to questions you may have, select any of the topics below to see a complete list of Q&As or scroll down. Don’t see what you’re looking for? Be sure to talk with your doctor.

 
 
 

Taking STEGLATRO

 
 
  • STEGLATRO is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes
  • STEGLATRO is not for people with type 1 diabetes
  • STEGLATRO is not for people with diabetic ketoacidosis (increased ketones in your blood or urine)

STEGLATRO was studied for 26 weeks in adults with type 2 diabetes whose A1C was not controlled with diet and exercise alone. In this clinical study, STEGLATRO helped people to:

Significantly lower A1C levels

  • STEGLATRO 5 mg lowered A1C an average of 0.7%, from 8.2% at start
  • STEGLATRO 15 mg lowered A1C an average of 0.8% from 8.4% at start
  • Placebo lowered A1C an average of 0.2%, from 8.1% at start

Reach A1C goals

In the same study, almost twice as many people who took the starting dose of STEGLATRO (5 mg) reached an A1C of less than 7% as compared to placebo.

Percent of people in the study who reached an A1C goal of less than 7%:

  • 30% who took STEGLATRO 5 mg
  • 39% who took STEGLATRO 15 mg
  • 17% who took placebo

For many adults with diabetes, the American Diabetes Association recommends an A1C goal of less than 7%. Be sure to talk to your doctor about what A1C goal is right for you.

Lose weight

Although it's not a weight loss medication, STEGLATRO may help you lose some weight.

In the same study, adults with type 2 diabetes who took STEGLATRO, along with diet and exercise, lost on average 4 pounds more than those taking placebo.

Average weight loss for people in the study:

  • STEGLATRO 5 mg: people lost an average of 6 pounds from 207 pounds at start
  • STEGLATRO 15 mg: people lost an average of 6 pounds from 200 pounds at start
  • Placebo: people lost an average of 2 pounds from 207 pounds at start

STEGLATRO is 1 pill, taken 1 time a day, and is available in 5 or 15 mg tablets. The starting dose of STEGLATRO is 5 mg.

Do not take STEGLATRO if you:

  • have severe kidney problems or are on dialysis
  • are allergic to ertugliflozin or any of the ingredients in STEGLATRO. Symptoms of a serious allergic reaction to STEGLATRO may include skin rash, raised red patches on your skin (hives), and swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing. If you have any symptoms of a serious allergic reaction, stop taking STEGLATRO and call your doctor right away.

The most common side effects of STEGLATRO include yeast infections of the vagina or penis, and changes in urination, including an urgent need to urinate more often, in larger amounts, or at night.

Be sure to take STEGLATRO exactly as your doctor tells you. Take STEGLATRO by mouth 1 (one) time in the morning each day—at that same time every day. You can take STEGLATRO with or without food. Your doctor may change your dose if needed.

If you miss a dose of STEGLATRO, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take 2 doses of STEGLATRO at the same time.

 

Savings on STEGLATRO

 

If you have been prescribed STEGLATRO, you may pay as little as $0 per prescription.*

Eligible, privately insured patients may pay as little as $0 per prescription on each of up to 12 qualifying prescriptions. Maximum savings is $583 per prescription. Learn More

*Not all patients are eligible. Certain restrictions apply. Please see Terms and Conditions.

 

Hello STEGLATRO Support Program

 

Hello STEGLATRO is a support program that can help you stay on track with your treatment. Sign up to receive helpful e-mails about a range of topics, such as:

  • Taking STEGLATRO
  • How STEGLATRO works
  • Special offers and more

Sign up now for Hello STEGLATRO.

 
 

 

TRUSTe Verified Privacy TRUSTe APEC Privacy

Copyright © 2019 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.

This site is intended only for residents of the United States, its territories, and Puerto Rico. US-STE-00656 07/19

Do not take STEGLATRO if you:

  • have severe kidney problems or are on dialysis
  • are allergic to ertugliflozin or any of the ingredients in STEGLATRO. Symptoms of a serious allergic reaction to STEGLATRO may include skin rash, raised red patches on your skin (hives), and swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing. If you have any symptoms of a serious allergic reaction, stop taking STEGLATRO and call your doctor right away.